Jia‐Huei Tsai

1.8k total citations
54 papers, 1.2k citations indexed

About

Jia‐Huei Tsai is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Jia‐Huei Tsai has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 20 papers in Surgery and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Jia‐Huei Tsai's work include Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Genetic factors in colorectal cancer (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Jia‐Huei Tsai is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Genetic factors in colorectal cancer (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Jia‐Huei Tsai collaborates with scholars based in Taiwan, United States and Australia. Jia‐Huei Tsai's co-authors include Jau‐Yu Liau, Yung‐Ming Jeng, Ray‐Hwang Yuan, Jen‐Chieh Lee, Ching‐Yao Yang, Hsin‐Jung Lee, Chih-Ning Chang, R A Hitchings, Simon Ruben and Chia‐Yu Chu and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Gut.

In The Last Decade

Jia‐Huei Tsai

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jia‐Huei Tsai Taiwan 20 492 490 337 261 258 54 1.2k
Jau‐Yu Liau Taiwan 25 841 1.7× 422 0.9× 414 1.2× 408 1.6× 488 1.9× 79 1.7k
Michael D. Linden United States 21 460 0.9× 298 0.6× 442 1.3× 299 1.1× 311 1.2× 53 1.3k
Andrea P. Subhawong United States 15 396 0.8× 234 0.5× 390 1.2× 203 0.8× 282 1.1× 29 933
Jun‐ichi Tamaru Japan 21 771 1.6× 290 0.6× 227 0.7× 862 3.3× 205 0.8× 108 1.5k
Eble Jn United States 5 371 0.8× 417 0.9× 434 1.3× 186 0.7× 439 1.7× 8 1.4k
Hyo Jeong Kang South Korea 21 665 1.4× 372 0.8× 270 0.8× 218 0.8× 255 1.0× 86 1.4k
Kurt T. Patton United States 16 276 0.6× 297 0.6× 335 1.0× 118 0.5× 308 1.2× 22 1.6k
Marie Karanian France 22 452 0.9× 106 0.2× 819 2.4× 291 1.1× 361 1.4× 68 1.3k
Junhun Cho South Korea 23 846 1.7× 268 0.5× 371 1.1× 568 2.2× 269 1.0× 106 1.5k
K.K. Ang United States 15 580 1.2× 390 0.8× 508 1.5× 65 0.2× 302 1.2× 59 1.4k

Countries citing papers authored by Jia‐Huei Tsai

Since Specialization
Citations

This map shows the geographic impact of Jia‐Huei Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia‐Huei Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia‐Huei Tsai more than expected).

Fields of papers citing papers by Jia‐Huei Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia‐Huei Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia‐Huei Tsai. The network helps show where Jia‐Huei Tsai may publish in the future.

Co-authorship network of co-authors of Jia‐Huei Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Jia‐Huei Tsai. A scholar is included among the top collaborators of Jia‐Huei Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia‐Huei Tsai. Jia‐Huei Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Sih‐Han, Jia‐Huei Tsai, Po‐Ting Chen, et al.. (2024). Comparison of the clinicoradiological features and outcomes of lymphoepithelioma-like cholangiocarcinoma and conventional intrahepatic cholangiocarcinoma: A propensity score matching analysis. Journal of the Formosan Medical Association. 124(8). 724–730.
2.
Ho, Ming‐Chih, Po‐Chu Lee, Po‐Jen Yang, et al.. (2024). Clinical performance of ultrasonic backscatter parametric and nonparametric statistics in detecting early hepatic steatosis. Ultrasonics. 142. 107391–107391. 1 indexed citations
3.
Jeng, Yung‐Ming, et al.. (2023). Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common Molecular Features With Its Conventional Carcinomatous Counterparts. Modern Pathology. 36(1). 100042–100042. 10 indexed citations
4.
Su, Tung‐Hung, Chun‐Jen Liu, Hung‐Chih Yang, et al.. (2023). Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis. Journal of the Formosan Medical Association. 123(1). 88–97. 2 indexed citations
5.
Chen, Kuo‐Hsing, Chia‐Lang Hsu, Yu‐Li Su, et al.. (2022). Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer. British Journal of Cancer. 128(1). 102–111. 2 indexed citations
6.
Chen, Kuo‐Hsing, et al.. (2021). Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells. Journal of Biomedical Science. 28(1). 75–75. 17 indexed citations
7.
Yuan, Chang‐Tsu, Jann‐Tay Wang, Wang‐Huei Sheng, et al.. (2021). Lymphadenopathy Associated With Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable From Malignant Lymphoma and Treatable by Antibiotics. The American Journal of Surgical Pathology. 45(8). 1138–1150. 5 indexed citations
8.
Tsai, Jia‐Huei, et al.. (2020). An Integrative Morphomolecular Classification System of Gastric Carcinoma With Distinct Clinical Outcomes. The American Journal of Surgical Pathology. 44(8). 1017–1030. 16 indexed citations
9.
10.
Liau, Jau‐Yu, Jia‐Huei Tsai, Wenchang Huang, et al.. (2017). BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin. Human Pathology. 73. 59–65. 19 indexed citations
11.
Yuan, Chang‐Tsu, et al.. (2017). NRASQ61R immunohistochemistry detects both NRASQ61R and KRASQ61R mutations in colorectal cancer. Pathology. 49(4). 387–390. 4 indexed citations
12.
Tsai, Jia‐Huei, Linda D. Ferrell, Vivian Tan, et al.. (2017). Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition. Modern Pathology. 30(6). 834–842. 41 indexed citations
13.
Liau, Jau‐Yu, Jui Lan, Jin‐Bon Hong, et al.. (2016). Frequent PIK3CA-activating mutations in hidradenoma papilliferums. Human Pathology. 55. 57–62. 16 indexed citations
14.
Liau, Jau‐Yu, Jia‐Huei Tsai, Yung‐Ming Jeng, et al.. (2015). The Diagnostic Utility of PAX8 for Neuroendocrine Tumors. Applied immunohistochemistry & molecular morphology. 24(1). 57–63. 27 indexed citations
15.
Liau, Jau‐Yu, Jen‐Chieh Lee, Jia‐Huei Tsai, et al.. (2015). Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas. Modern Pathology. 28(12). 1545–1554. 55 indexed citations
16.
Lee, Jen‐Chieh, et al.. (2015). Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas. Modern Pathology. 28(8). 1064–1073. 42 indexed citations
17.
Tsai, Jia‐Huei, Jau‐Yu Liau, Yulin Lin, et al.. (2014). Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis. Modern Pathology. 27(10). 1375–1385. 68 indexed citations
18.
Liau, Jau‐Yu, et al.. (2014). Leiomyosarcoma With Alternative Lengthening of Telomeres Is Associated With Aggressive Histologic Features, Loss of ATRX Expression, and Poor Clinical Outcome. The American Journal of Surgical Pathology. 39(2). 236–244. 75 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jau‐Yu Liau Breakdown of academic impact, for papers by Michael D. Linden Breakdown of academic impact, for papers by Andrea P. Subhawong Breakdown of academic impact, for papers by Jun‐ichi Tamaru Breakdown of academic impact, for papers by Eble Jn Breakdown of academic impact, for papers by Hyo Jeong Kang Breakdown of academic impact, for papers by Kurt T. Patton Breakdown of academic impact, for papers by Marie Karanian Breakdown of academic impact, for papers by Junhun Cho Breakdown of academic impact, for papers by K.K. Ang
Rankless by CCL
2026